Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lazer

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|July 1, 1990
Effect of structure on potency and selectivity in 2,6-disubstituted 4-(2-arylethenyl)phenol lipoxygenase inhibitorsE S Lazer, H C Wong, C D Wegner, et al.
Journal of Medicinal Chemistry|January 1, 1989
Antiinflammatory 2,6-di-tert-butyl-4-(2-arylethenyl)phenolsE S Lazer, H C Wong, G J Possanza, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1991
The effects of a 5-lipoxygenase inhibitor on antigen-induced mediator release, late-phase bronchoconstriction and cellular infiltrates in primatesR H Gundel, C A Torcellini, C C Clarke, et al.
Maturitas|November 1, 1994
Acceptability and skin reactions to transdermal estrogen replacement therapy in relation to climateY Frenkel, G Kopernik, S Lazer, et al.
Agents and Actions|September 1, 1991
BI-L-239, a 5-lipoxygenase inhibitor, blocks inhaled antigen-induced airway hyperresponsiveness in conscious guinea pigsW W Wolyniec, A M LaPlante, M Kontny, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Antiinflammatory 2-benzyl-4-sulfonyl-4H-isoquinoline-1,3-diones: novel inhibitors of COX-2E S Lazer, R Sorcek, C L Cywin, et al.
Journal of Pharmaceutical Sciences|December 1, 1978
Synthesis and biological activity of cocaine analogs I: N-alkylated norcocaine derivativesE S Lazer, N D Aggarwal, G J Hite, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1993
A prodrug of a 2,6-disubstituted 4-(2-arylethenyl)phenol is a selective and orally active 5-lipoxygenase inhibitorP R Farina, A G Graham, C A Homon, et al.
Journal of Medicinal Chemistry|April 1, 1994
Benzoxazolamines and benzothiazolamines: potent, enantioselective inhibitors of leukotriene biosynthesis with a novel mechanism of actionE S Lazer, C K Miao, H C Wong, et al.
Agents and Actions. Supplements|January 1, 1995
Inhibition of lipid mediator biosynthesis in human inflammatory cells by BIRM 270T P Parks, A F Hoffman, C A Homon, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|July 1, 1990
Effect of structure on potency and selectivity in 2,6-disubstituted 4-(2-arylethenyl)phenol lipoxygenase inhibitorsE S Lazer, H C Wong, C D Wegner, et al.
Journal of Medicinal Chemistry|January 1, 1989
Antiinflammatory 2,6-di-tert-butyl-4-(2-arylethenyl)phenolsE S Lazer, H C Wong, G J Possanza, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1991
The effects of a 5-lipoxygenase inhibitor on antigen-induced mediator release, late-phase bronchoconstriction and cellular infiltrates in primatesR H Gundel, C A Torcellini, C C Clarke, et al.
Maturitas|November 1, 1994
Acceptability and skin reactions to transdermal estrogen replacement therapy in relation to climateY Frenkel, G Kopernik, S Lazer, et al.
Agents and Actions|September 1, 1991
BI-L-239, a 5-lipoxygenase inhibitor, blocks inhaled antigen-induced airway hyperresponsiveness in conscious guinea pigsW W Wolyniec, A M LaPlante, M Kontny, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Antiinflammatory 2-benzyl-4-sulfonyl-4H-isoquinoline-1,3-diones: novel inhibitors of COX-2E S Lazer, R Sorcek, C L Cywin, et al.
Journal of Pharmaceutical Sciences|December 1, 1978
Synthesis and biological activity of cocaine analogs I: N-alkylated norcocaine derivativesE S Lazer, N D Aggarwal, G J Hite, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1993
A prodrug of a 2,6-disubstituted 4-(2-arylethenyl)phenol is a selective and orally active 5-lipoxygenase inhibitorP R Farina, A G Graham, C A Homon, et al.
Journal of Medicinal Chemistry|April 1, 1994
Benzoxazolamines and benzothiazolamines: potent, enantioselective inhibitors of leukotriene biosynthesis with a novel mechanism of actionE S Lazer, C K Miao, H C Wong, et al.
Agents and Actions. Supplements|January 1, 1995
Inhibition of lipid mediator biosynthesis in human inflammatory cells by BIRM 270T P Parks, A F Hoffman, C A Homon, et al.
Pageof 3